4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-052347
Chief Executive Officer sold 12,563 shares at $19.59 ($246,109)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2024-12-23 | Sale 10b5-1 | −12,563 | $19.59 | $246,109 | 3,775,772 | D |
| Open-market sales · 12,563 sh · avg $19.59 · $246,109 | |||||||
Loading xslF345X05/wk-form4_1734989985.xml…